US Stock MarketDetailed Quotes
ALNY Alnylam Pharmaceuticals
- 245.440
- +6.570+2.75%
Close Dec 20 16:00 ET
- 245.440
- 0.0000.00%
Post 16:59 ET
31.66BMarket Cap-93.68P/E (TTM)
247.210High235.930Low1.66MVolume239.450Open238.870Pre Close407.73MTurnover1.30%Turnover RatioLossP/E (Static)128.98MShares304.39052wk High977.85P/B31.52BFloat Cap141.97552wk Low--Dividend TTM128.43MShs Float304.390Historical High--Div YieldTTM4.72%Amplitude3.650Historical Low245.092Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Alnylam Pharmaceuticals Stock Forum
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet